A phase III study of oral steroid administration versus local steroid injection therapy for the prevention of esophageal stricture after endoscopic submucosal dissection(JCOG1217, Steroid EESD P3) - A phase III study of oral steroid administration versus local steroid injection therapy for the prevention of esophageal stricture after endoscopic submucosal dissection(JCOG1217, Steroid EESD P3)

Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 360 人开始时间: 2014年9月5日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Synchronous or metachronous (within 1 years) malignancies 2) Active infection requiring systemic therapy 3) Body temperature >=38 degrees Celsius 4) Pregnancy, possible pregnancy, within 28 days after delivery or breastfeeding 5) Severe psychiatric disease 6) Patients requiring systemic steroid medication 7) Uncontrollable diabetes mellitus 8) Patients requiring continuous anticoagulant or antiplatelet drug 9) Poorly controlled hypertension 10) Histody of unstable angina within 3 weeks or myocardial infarction within 6 months 11) Patients with respiratory disease requiring continuous supplemental oxygen 12) Active gastroduodenal ulcer 13) Glaucoma, posterior capsule opacification or herpetic keratitis 14) History of surgery within 3 months 15) Positive HBs antigen, HBs antibody or HBc antibody 16) Allergy to Iodine 17) Hypersensitivity for triamcinolone acetonide, prednisolone, and proton pump inhibitor 18) Glucose-6-phosphate dehydrogenase deficiency

发起方

Japan Clinical Oncology Group (JCOG)